Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
Free Radic Biol Med ; 147: 231-241, 2020 02 01.
Article in English | MEDLINE | ID: mdl-31883467

ABSTRACT

High fidelity and effective adaptive changes of the cell and tissue metabolism to changing environments require strict coordination of numerous biological processes. Multicellular organisms developed sophisticated signaling systems of monitoring and responding to these different contexts. Among these systems, oxygenated lipids play a significant role realized via a variety of re-programming mechanisms. Some of them are enacted as a part of pro-survival pathways that eliminate harmful or unnecessary molecules or organelles by a variety of degradation/hydrolytic reactions or specialized autophageal processes. When these "partial" intracellular measures are insufficient, the programs of cells death are triggered with the aim to remove irreparably damaged members of the multicellular community. These regulated cell death mechanisms are believed to heavily rely on signaling by a highly diversified group of molecules, oxygenated phospholipids (PLox). Out of thousands of detectable individual PLox species, redox phospholipidomics deciphered several specific molecules that seem to be diagnostic of specialized death programs. Oxygenated cardiolipins (CLs) and phosphatidylethanolamines (PEs) have been identified as predictive biomarkers of apoptosis and ferroptosis, respectively. This has led to decoding of the enzymatic mechanisms of their formation involving mitochondrial oxidation of CLs by cytochrome c and endoplasmic reticulum-associated oxidation of PE by lipoxygenases. Understanding of the specific biochemical radical-mediated mechanisms of these oxidative reactions opens new avenues for the design and search of highly specific regulators of cell death programs. This review emphasizes the usefulness of such selective lipid peroxidation mechanisms in contrast to the concept of random poorly controlled free radical reactions as instruments of non-specific damage of cells and their membranes. Detailed analysis of two specific examples of phospholipid oxidative signaling in apoptosis and ferroptosis along with their molecular mechanisms and roles in reprogramming has been presented.


Subject(s)
Ferroptosis , Phospholipids , Apoptosis , Cell Death , Oxidation-Reduction
2.
Cell Death Differ ; 23(7): 1140-51, 2016 07.
Article in English | MEDLINE | ID: mdl-26742431

ABSTRACT

Mitophagy is critical for cell homeostasis. Externalization of the inner mitochondrial membrane phospholipid, cardiolipin (CL), to the surface of the outer mitochondrial membrane (OMM) was identified as a mitophageal signal recognized by the microtubule-associated protein 1 light chain 3. However, the CL-translocating machinery remains unknown. Here we demonstrate that a hexameric intermembrane space protein, NDPK-D (or NM23-H4), binds CL and facilitates its redistribution to the OMM. We found that mitophagy induced by a protonophoric uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP), caused externalization of CL to the surface of mitochondria in murine lung epithelial MLE-12 cells and human cervical adenocarcinoma HeLa cells. RNAi knockdown of endogenous NDPK-D decreased CCCP-induced CL externalization and mitochondrial degradation. A R90D NDPK-D mutant that does not bind CL was inactive in promoting mitophagy. Similarly, rotenone and 6-hydroxydopamine triggered mitophagy in SH-SY5Y cells was also suppressed by knocking down of NDPK-D. In situ proximity ligation assay (PLA) showed that mitophagy-inducing CL-transfer activity of NDPK-D is closely associated with the dynamin-like GTPase OPA1, implicating fission-fusion dynamics in mitophagy regulation.


Subject(s)
Cardiolipins/metabolism , Mitochondria/metabolism , Mitochondrial Membranes/metabolism , Mitophagy , Nucleoside Diphosphate Kinase D/metabolism , Animals , Autophagy/drug effects , Carbonyl Cyanide m-Chlorophenyl Hydrazone/toxicity , Cardiolipins/analysis , Cell Line , GTP Phosphohydrolases/metabolism , HeLa Cells , Humans , Lysosomes/metabolism , Lysosomes/pathology , Mice , Microtubule-Associated Proteins/metabolism , Mitochondria/pathology , Mitophagy/drug effects , Mutagenesis, Site-Directed , Nucleoside Diphosphate Kinase D/antagonists & inhibitors , Nucleoside Diphosphate Kinase D/genetics , Oxidopamine/pharmacology , Protein Binding , RNA Interference , Rotenone/pharmacology
3.
Cell Death Dis ; 6: e1630, 2015 Feb 05.
Article in English | MEDLINE | ID: mdl-25654763

ABSTRACT

Fbxl7, a subunit of the SCF (Skp-Cul1-F-box protein) complex induces mitotic arrest in cells; however, molecular factors that control its cellular abundance remain largely unknown. Here, we identified that an orphan F-box protein, Fbxl18, targets Fbxl7 for its polyubiquitylation and proteasomal degradation. Lys 109 within Fbxl7 is an essential acceptor site for ubiquitin conjugation by Fbxl18. An FQ motif within Fbxl7 serves as a molecular recognition site for Fbxl18 interaction. Ectopically expressed Fbxl7 induces apoptosis in Hela cells, an effect profoundly accentuated after cellular depletion of Fbxl18 protein or expression of Fbxl7 plasmids encoding mutations at either Lys 109 or within the FQ motif. Ectopic expression of Fbxl18 plasmid-limited apoptosis caused by overexpressed Fbxl7 plasmid. Thus, Fbxl18 regulates apoptosis by mediating ubiquitin-dependent proteasomal degradation of the pro-apoptotic protein Fbxl7 that may impact cellular processes involved in cell cycle progression.


Subject(s)
Apoptosis , F-Box Proteins/metabolism , Polyubiquitin/metabolism , Proteasome Endopeptidase Complex/metabolism , Protein Subunits/metabolism , Ubiquitination , Amino Acid Motifs , Animals , Binding Sites , Cell Line , DNA-Binding Proteins , F-Box Proteins/chemistry , Humans , Lysine/metabolism , Mice , Protein Structure, Tertiary , Protein Subunits/chemistry , Proteolysis
4.
Mucosal Immunol ; 8(4): 896-905, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25492474

ABSTRACT

Neutrophil elastase (NE) and cathepsin G (CG) contribute to intracellular microbial killing but, if left unchecked and released extracellularly, promote tissue damage. Conversely, mechanisms that constrain neutrophil serine protease activity protect against tissue damage but may have the untoward effect of disabling the microbial killing arsenal. The host elaborates thrombospondin-1 (TSP-1), a matricellular protein released during inflammation, but its role during neutrophil activation following microbial pathogen challenge remains uncertain. Mice deficient in TSP-1 (thbs1(-/-)) showed enhanced lung bacterial clearance, reduced splenic dissemination, and increased survival compared with wild-type (WT) controls during intrapulmonary Klebsiella pneumoniae infection. More effective pathogen containment was associated with reduced burden of inflammation in thbs1(-/-) mouse lungs compared with WT controls. Lung NE activity was increased in thbs1(-/-) mice following K. pneumoniae challenge, and thbs1(-/-) neutrophils showed enhanced intracellular microbial killing that was abrogated with recombinant TSP-1 administration or WT serum. Thbs1(-/-) neutrophils exhibited enhanced NE and CG enzymatic activity, and a peptide corresponding to amino-acid residues 793-801 within the type-III repeat domain of TSP-1 bridled neutrophil proteolytic function and microbial killing in vitro. Thus, TSP-1 restrains proteolytic action during neutrophilic inflammation elicited by K. pneumoniae, providing a mechanism that may regulate the microbial killing arsenal.


Subject(s)
Immunity, Innate , Klebsiella Infections/immunology , Klebsiella Infections/metabolism , Klebsiella pneumoniae/immunology , Neutrophils/immunology , Neutrophils/metabolism , Serine Proteases/metabolism , Thrombospondin 1/metabolism , Animals , Cathepsin G/metabolism , Cytotoxicity, Immunologic , Disease Models, Animal , Klebsiella Infections/mortality , Klebsiella Infections/pathology , Leukocyte Elastase/metabolism , Lung/immunology , Lung/metabolism , Lung/microbiology , Lung/pathology , Mice , Mice, Knockout , Neutrophils/drug effects , Peptides/pharmacology , Recombinant Proteins/pharmacology , Respiratory Burst/genetics , Respiratory Burst/immunology , Spleen/immunology , Spleen/metabolism , Spleen/microbiology , Thrombospondin 1/chemistry , Thrombospondin 1/deficiency , Thrombospondin 1/genetics , Thrombospondin 1/pharmacology
5.
Cell Death Dis ; 4: e759, 2013 Aug 08.
Article in English | MEDLINE | ID: mdl-23928698

ABSTRACT

Aurora B kinase is an integral regulator of cytokinesis, as it stabilizes the intercellular canal within the midbody to ensure proper chromosomal segregation during cell division. Here we identified that the ubiquitin E3 ligase complex SCF(FBXL2) mediates Aurora B ubiquitination and degradation within the midbody, which is sufficient to induce mitotic arrest and apoptosis. Three molecular acceptor sites (K¹°², K¹°³ and K²°7) within Aurora B protein were identified as important sites for its ubiquitination. A triple Lys mutant of Aurora B (K¹°²/¹°³/(²°7R)) exhibited optimal resistance to SCF(FBXL2)-directed polyubiquitination, and overexpression of this variant resulted in a significant delay in anaphase onset, resulting in apoptosis. A unique small molecule F-box/LRR-repeat protein 2 (FBXL2) activator, BC-1258, stabilized and increased levels of FBXL2 protein that promoted Aurora B degradation, resulting in tetraploidy, mitotic arrest and apoptosis of tumorigenic cells, and profoundly inhibiting tumor formation in athymic nude mice. These findings uncover a new proteolytic mechanism targeting a key regulator of cell replication that may serve as a basis for chemotherapeutic intervention in neoplasia.


Subject(s)
Aurora Kinase B/metabolism , Carcinogenesis/genetics , F-Box Proteins/physiology , Animals , Apoptosis , F-Box Proteins/metabolism , G2 Phase Cell Cycle Checkpoints , Mice , Mice, Nude , Polyploidy , Ubiquitination
6.
Mucosal Immunol ; 6(1): 189-99, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22785228

ABSTRACT

Bacterial pneumonia remains a significant burden worldwide. Although an inflammatory response in the lung is required to fight the causative agent, persistent tissue-resident neutrophils in non-resolving pneumonia can induce collateral tissue damage and precipitate acute lung injury. However, little is known about mechanisms orchestrated in the lung tissue that remove apoptotic neutrophils to restore tissue homeostasis. In mice infected with Klebsiella pneumoniae, a bacterium commonly associated with hospital-acquired pneumonia, we show that interleukin (IL)-10 is essential for resolution of lung inflammation and recovery of mice after infection. Although IL-10(-/-) mice cleared bacteria, they displayed increased morbidity with progressive weight loss and persistent lung inflammation in the later phase after infection. A source of tissue IL-10 was found to be resident CD11b(+)Gr1(int)F4/80(+) cells resembling myeloid-derived suppressor cells (MDSCs) that appeared with a delayed kinetics after infection. These cells efficiently efferocytosed apoptotic neutrophils, which was aided by IL-10. The lung neutrophil burden was attenuated in infected signal transducer and activator of transcription 1 (STAT1)(-/-) mice with concomitant increase in the frequency of the MDSC-like cells and lung IL-10 levels. Thus, inhibiting STAT1 in combination with antibiotics may be a novel therapeutic strategy to address inefficient resolution of bacterial pneumonia.


Subject(s)
Interleukin-10/biosynthesis , Myeloid Cells/immunology , Myeloid Cells/metabolism , Neutrophils/immunology , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/metabolism , STAT1 Transcription Factor/metabolism , Animals , Apoptosis/immunology , Interleukin-10/genetics , Klebsiella pneumoniae/immunology , Male , Mice , Mice, Knockout , Pneumonia, Bacterial/genetics , Pneumonia, Bacterial/mortality , STAT1 Transcription Factor/genetics
7.
Oncogene ; 31(20): 2566-79, 2012 May 17.
Article in English | MEDLINE | ID: mdl-22020328

ABSTRACT

Dysregulated behavior of cell cycle proteins and their control by ubiquitin E3 ligases is an emerging theme in human lung cancer. Here, we identified and characterized the activity of a novel F-box protein, termed FBXL2, belonging to the SCF (Skip-Cullin1-F-box protein) E3 ligase family. Ectopically expressed FBXL2 triggered G2/M-phase arrest, induced chromosomal anomalies and increased apoptosis of transformed lung epithelia by mediating polyubiquitination and degradation of the mitotic regulator, cyclin D3. Unlike other F-box proteins that target phosphodegrons within substrates, FBXL2 uniquely recognizes a canonical calmodulin (CaM)-binding motif within cyclin D3 to facilitate its polyubiquitination. CaM bound and protected cyclin D3 from FBXL2 by direct intermolecular competition with the F-box protein for access within this motif. The chemotherapeutic agent vinorelbine increased apoptosis of human lung carcinoma cells by inducing FBXL2 expression and cyclin D3 degradation, an effect accentuated by CaM knockdown. Depletion of endogenous FBXL2 stabilized cyclin D3 levels, accelerated cancer cell growth and increased cell viability after vinorelbine treatment. Last, ectopic expression of FBXL2 significantly inhibited the growth and migration of tumorogenic cells and tumor formation in athymic nude mice. These observations implicate SCF(FBXL2) as an indispensible regulator of mitosis that serves as a tumor suppressor.


Subject(s)
Adenocarcinoma , Cell Cycle Checkpoints , Cyclin D3/metabolism , F-Box Proteins/metabolism , Lung Neoplasms , Lung , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenocarcinoma of Lung , Animals , Apoptosis , Cell Line, Transformed , Cell Line, Tumor , Cell Proliferation , Cell Survival , Humans , Lung/pathology , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Mice , SKP Cullin F-Box Protein Ligases/metabolism , Tumor Suppressor Proteins/metabolism , Ubiquitination
8.
Gene Ther ; 13(12): 974-85, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16511521

ABSTRACT

Surfactant deficiency is an important contributor to the acute respiratory distress syndrome, a disorder that commonly occurs after bacterial sepsis. CTP:phosphocholine cytidylyltransferase (CCTalpha) is the rate-limiting enzyme required for the biosynthesis of dipalmitoylphosphatidylcholine (DPPC), the major phospholipid of surfactant. In this study, a cDNA encoding a novel, calpain-resistant mutant CCTalpha enzyme was delivered intratracheally in mice using a replication-deficient adenovirus 5 CTP:phosphocholine cytidylyltransferase construct (Ad5-CCT(Penta)) in models of bacterial sepsis. Ad5-CCT(Penta) gene transfer produced high-level CCTalpha gene expression, increased alveolar surfactant (DPPC) levels and improved lung surface tension and pressure-volume relationships relative to control mice. Pseudomonas aeruginosa (PA103) decreased DPPC synthesis, in part, via calpain-mediated degradation of CCTalpha. Deleterious effects of Pseudomonas on surfactant were lessened after infection with a mutant strain lacking the type III exotoxin, Exo U. Replication-deficient adenovirus 5 CTP:phosphocholine cytidylyltransferase gene delivery improved lung biophysical properties by optimizing surface activity in this Pseudomonas model of proteinase-mediated lung injury. The studies are the first demonstration of in vivo gene transfer of a lipogenic enzyme resulting in improved lung mechanics. The studies suggest that augmentation of DPPC synthesis via gene delivery of CCTalpha can attenuate impaired lung function in surfactant-deficient states such as bacterial sepsis.


Subject(s)
Choline-Phosphate Cytidylyltransferase/genetics , Genetic Therapy/methods , Lung Diseases/therapy , Pseudomonas Infections/therapy , Pulmonary Surfactants/administration & dosage , 1,2-Dipalmitoylphosphatidylcholine/metabolism , Acute Disease , Adenoviridae/genetics , Animals , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/metabolism , Choline-Phosphate Cytidylyltransferase/administration & dosage , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Lung/enzymology , Lung Diseases/enzymology , Male , Mice , Mice, Inbred C57BL , Pseudomonas Infections/enzymology , Transduction, Genetic/methods
9.
J Immunol ; 167(10): 5977-85, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11698477

ABSTRACT

The phosphatidylinositol (PI) 3-kinase pathway is an important regulator of cell survival. In human alveolar macrophages, we found that LPS activates PI 3-kinase and its downstream effector, Akt. LPS exposure of alveolar macrophages also results in the generation of ceramide. Because ceramide exposure induces apoptosis in other cell types and the PI 3-kinase pathway is known to inhibit apoptosis, we determined the relationship between LPS-induced ceramide and PI 3-kinase activation in alveolar macrophages. We found that ceramide exposure activated PI 3-kinase and Akt. When we blocked LPS-induced ceramide with the inhibitor D609, we blocked LPS-induced PI 3-kinase and Akt activation. Evaluating cell survival after ceramide or LPS exposure, we found that blocking PI 3-kinase induced a significant increase in cell death. Because these effects of PI 3-kinase inhibition were more pronounced in ceramide- vs LPS-treated alveolar macrophages, we also evaluated NF-kappaB, which has also been linked to cell survival. We found that LPS, to a greater degree than ceramide, induced NF-kappaB translocation to the nucleus. As a composite, these studies suggest that the effects of ceramide exposure in alveolar macrophages may be very different from the effects described for other cell types. We believe that LPS induction of ceramide results in PI 3-kinase activation and represents a novel effector mechanism that promotes survival of human alveolar macrophages in the setting of pulmonary sepsis.


Subject(s)
Apoptosis , Ceramides/pharmacology , Lipopolysaccharides/pharmacology , Macrophages, Alveolar/immunology , Phosphatidylinositol 3-Kinases/metabolism , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins/metabolism , Active Transport, Cell Nucleus , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Nucleus/metabolism , Cells, Cultured , Ceramides/biosynthesis , Enzyme Activation , Glycogen Synthase Kinase 3 , Humans , Macrophages, Alveolar/cytology , Macrophages, Alveolar/enzymology , Models, Biological , NF-kappa B/metabolism , Phosphorylation , Proto-Oncogene Proteins c-akt , Type C Phospholipases/pharmacology
10.
J Lipid Res ; 41(8): 1268-77, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10946015

ABSTRACT

We examined the effect of lipoprotein deprivation on the expression of the rate-regulatory enzyme involved in phosphatidylcholine (PtdCho) synthesis, phosphocholine cytidylyltransferase (CCT), within an alveolar type II epithelial cell line (MLE-12). Compared with cells exposed to 10% fetal bovine serum (FBS, control), cells cultured with lipoprotein-deficient serum (LPDS) for 72 h had a 150% increase in CCT activity. Stimulation of CCT activity after LPDS exposure was associated with a 2-fold increase in immunoreactive CCT content and a corresponding increase in [(35)S]methionine incorporation into newly synthesized CCT. LPDS induction of CCT protein was reversible, as it was suppressed to baseline levels by the addition of low density lipoproteins to the culture medium. Northern blotting revealed that LPDS increased CCT mRNA levels 2-fold compared with control. The induction of CCT mRNA by LPDS was not associated with an increase in mRNA half-life. Nuclear run-on assays revealed that LPDS-induced expression of CCT was due, at least in part, to an increase in gene transcription. These studies reveal that lipoprotein deprivation upregulates the activity of a key enzyme involved in the PtdCho biosynthetic pathway. LPDS induction of CCT protein might serve as a novel compensatory mechanism in response to lipid deprivation by increasing cellular transcription of the CCT gene.


Subject(s)
Choline-Phosphate Cytidylyltransferase/genetics , Lipoproteins/deficiency , Transcription, Genetic , Animals , Blood , Blotting, Northern , Choline-Phosphate Cytidylyltransferase/biosynthesis , Culture Media , Epithelial Cells/enzymology , Half-Life , Immunoblotting , Lipoproteins/blood , Phosphatidylcholines/biosynthesis , Pulmonary Alveoli/enzymology , RNA, Messenger/analysis , RNA, Messenger/metabolism
11.
J Biol Chem ; 275(13): 9699-708, 2000 Mar 31.
Article in English | MEDLINE | ID: mdl-10734122

ABSTRACT

We investigated the effects of tumor necrosis factor alpha (TNFalpha), a key cytokine involved in inflammatory lung disease, on phosphatidylcholine (PtdCho) biosynthesis in a murine alveolar type II epithelial cell line (MLE-12). TNFalpha significantly inhibited [(3)H]choline incorporation into PtdCho after 24 h of exposure. TNFalpha reduced the activity of CTP:phosphocholine cytidylyltransferase (CCT), the rate-regulatory enzyme within the CDP-choline pathway, by 40% compared with control, but it did not alter activities of choline kinase or cholinephosphotransferase. Immunoblotting revealed that TNFalpha inhibition of CCT activity was associated with a uniform decrease in the mass of CCTalpha in total cell lysates, cytosolic, microsomal, and nuclear subfractions of MLE cells. Northern blotting revealed no effects of the cytokine on steady-state levels of CCTalpha mRNA, and CCTbeta mRNA was not detected. Incorporation of [(35)S]methionine into immunoprecipitable CCTalpha protein in pulse and pulse-chase studies revealed that TNFalpha did not alter de novo synthesis of enzyme, but it substantially accelerated turnover of CCTalpha. Addition of N-acetyl-Leu-Leu-Nle-CHO (ALLN), the calpain I inhibitor, or lactacystin, the 20 S proteasome inhibitor, blocked the inhibition of PtdCho biosynthesis mediated by TNFalpha. TNFalpha-induced degradation of CCTalpha protein was partially blocked by ALLN or lactacystin. CCT was ubiquitinated, and ubiquitination increased after TNFalpha exposure. m-Calpain degraded both purified CCT and CCT in cellular extracts. Thus, TNFalpha inhibits PtdCho synthesis by modulating CCT protein stability via the ubiquitin-proteasome and calpain-mediated proteolytic pathways.


Subject(s)
Choline-Phosphate Cytidylyltransferase/antagonists & inhibitors , Tumor Necrosis Factor-alpha/pharmacology , Amino Acid Sequence , Blotting, Western , Cell Line , Choline-Phosphate Cytidylyltransferase/genetics , Choline-Phosphate Cytidylyltransferase/metabolism , Hydrolysis , Molecular Sequence Data , Precipitin Tests , Protease Inhibitors/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Ubiquitins/immunology
12.
J Appl Physiol (1985) ; 88(1): 10-6, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10642356

ABSTRACT

Tumor necrosis factor-alpha (TNF-alpha) has been shown to play an integral role in the pathogenesis of the acute respiratory distress syndrome. This disorder is characterized by a deficiency of alveolar surfactant, a surface-active material that is composed of key hydrophobic proteins and the major lipid disaturated phosphatidylcholine (DSPC). We investigated how TNF-alpha might alter DSPC content in rat lungs by instilling the cytokine (2.5 microg) intratracheally for 10 min and then assaying parameters of DSPC synthesis and degradation in alveolar type II epithelial cells, which produce surfactant. Cells isolated from rats given TNF-alpha had 26% lower levels of phosphatidylcholine compared with control. TNF-alpha treatment also decreased the ability of these cells to incorporate [(3)H]choline into DSPC by 45% compared with control isolates. There were no significant differences in the levels of choline substrate or choline transport between the groups. However, TNF-alpha produced a 64% decrease in the activity of cytidylyltransferase, the rate-regulatory enzyme required for DSPC synthesis. TNF-alpha administration in vivo also tended to stimulate phospholipase A(2) activity, but it did not alter other parameters for DSPC degradation such as activities for phosphatidylcholine-specific phospholipase C or phospholipase D. These observations indicate that TNF-alpha decreases the levels of surfactant lipid by decreasing the activity of a key enzyme involved in surfactant lipid synthesis. The results do not exclude stimulatory effects of the cytokine on phosphatidylcholine breakdown.


Subject(s)
Pulmonary Alveoli/metabolism , Pulmonary Surfactants/metabolism , Respiratory Mucosa/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Animals , Biological Transport/drug effects , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Cell Survival/drug effects , Choline/metabolism , Choline-Phosphate Cytidylyltransferase/metabolism , Enzyme Activation/drug effects , Male , Organ Size/drug effects , Phosphatidylcholines/biosynthesis , Phosphatidylcholines/metabolism , Phospholipases A/metabolism , Pulmonary Alveoli/chemistry , Pulmonary Alveoli/cytology , Pulmonary Alveoli/drug effects , Pulmonary Surfactants/chemistry , Rats , Rats, Sprague-Dawley , Respiratory Mucosa/cytology , Respiratory Mucosa/drug effects , Trachea , Tumor Necrosis Factor-alpha/administration & dosage
13.
Pediatr Res ; 46(6): 722-30, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10590030

ABSTRACT

Delayed lung maturation and lower levels of surfactant phosphatidylcholine have been previously identified in male fetuses compared with female fetuses in several species. We investigated the mechanisms for sex differences in surfactant content by examining parameters of phosphatidylcholine turnover and biosynthesis; the latter was evaluated by measuring metabolic steps within the biosynthetic pathway. Compared with male lung cells, freshly isolated lung cells from female fetuses contained higher levels of disaturated phosphatidylcholine, a marker of surfactant lipid. Female mixed monolayer cultures exhibited a 71% increase in choline incorporation into disaturated phosphatidylcholine compared with male cultures. Male cultures exhibited significantly greater release of [3H]-arachidonic acid into the medium compared with females, suggesting sex differences in phospholipase activity. However, pulse-chase studies showed no sex differences in degradation of disaturated phosphatidylcholine, which was confirmed by assays of phospholipase A2, phosphatidylcholine-specific phospholipase C, and phospholipase D. Female mixed lung cells, however, had greater rates of cellular choline transport and activity of cytidylyltransferase, the rate-regulatory enzyme for phosphatidylcholine synthesis. Separate studies showed that exposure of sex-specific pretype II cell cultures to cortisol-stimulated fibroblast-conditioned medium plus transforming growth factor-beta-neutralizing antibody stimulated cytidylyltransferase activity to a greater extent in male cells compared with female cells. These studies indicate that sex differences in surfactant phospholipid content are not due to differences in phospholipid turnover, but rather differential regulation of specific metabolic steps within the surfactant biosynthetic pathway. The data also support a role for transforming growth factor-beta as a negative regulator of a key surfactant biosynthetic enzyme within male lungs.


Subject(s)
Lung/physiology , Pulmonary Surfactants/biosynthesis , Animals , Cells, Cultured , Female , Male , Rats , Rats, Sprague-Dawley , Sex Factors
14.
Am J Physiol ; 276(3): L481-90, 1999 03.
Article in English | MEDLINE | ID: mdl-10070113

ABSTRACT

Ceramide is a bioactive lipid mediator that has been observed to induce apoptosis in vitro. The purpose of this study was to determine whether endogenous ceramide, generated in response to in vivo administration of tumor necrosis factor-alpha (TNF-alpha), increases apoptosis in primary rat alveolar type II epithelial cells. Intratracheal instillation of TNF-alpha (5 microgram) produced a decrease in sphingomyelin and activation of a neutral sphingomyelinase. These changes were associated with a significant increase in lung ceramide content. TNF-alpha concomitantly activated the p42/44 extracellular signal-related kinases and induced nuclear factor-kappaB activation in the lung. Hypodiploid nuclei studies revealed that intratracheal TNF-alpha did not increase type II cell apoptosis compared with that in control cells after isolation. A novel observation from separate in vitro studies demonstrated that type II cells undergo a gradual increase in apoptosis after time in culture, a process that was accelerated by exposure of cells to ultraviolet light. However, culture of cells with a cell-permeable ceramide, TNF-alpha, or a related ligand, anti-CD95, did not increase apoptosis above the control level. The results suggest that ceramide resulting from TNF-alpha activation of sphingomyelin hydrolysis might activate the mitogen-activated protein kinase and nuclear factor-kappaB pathways without increasing programmed cell death in type II cells.


Subject(s)
Apoptosis/drug effects , Ceramides/metabolism , Pulmonary Alveoli/physiology , Tumor Necrosis Factor-alpha/pharmacology , Animals , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Nucleus/physiology , Cells, Cultured , Diploidy , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/physiology , Hydrolysis/drug effects , NF-kappa B/metabolism , Phospholipids/metabolism , Pulmonary Alveoli/cytology , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/metabolism , Rats , Rats, Sprague-Dawley , Sphingomyelins/biosynthesis , Sphingomyelins/metabolism
15.
J Immunol ; 162(5): 3005-12, 1999 Mar 01.
Article in English | MEDLINE | ID: mdl-10072552

ABSTRACT

This study uses human alveolar macrophages to determine whether activation of a phosphatidylcholine (PC)-specific phospholipase C (PC-PLC) is linked to activation of the p42/44 (ERK) kinases by LPS. LPS-induced ERK kinase activation was inhibited by tricyclodecan-9-yl xanthogenate (D609), a relatively specific inhibitor of PC-PLC. LPS also increased amounts of diacylglycerol (DAG), and this increase in DAG was inhibited by D609. LPS induction of DAG was, at least in part, derived from PC hydrolysis. Ceramide was also increased in LPS-treated alveolar macrophages, and this increase in ceramide was inhibited by D609. Addition of exogenous C2 ceramide or bacterial-derived sphingomyelinase to alveolar macrophages increased ERK kinase activity. LPS also activated PKC zeta, and this activation was inhibited by D609. LPS-activated PKC zeta phosphorylated MAP kinase kinase, the kinase directly upstream of the ERK kinases. LPS-induced cytokine production (RNA and protein) was also inhibited by D609. As an aggregate, these studies support the hypothesis that one way by which LPS activates the ERK kinases is via activation of PC-PLC and that activation of a PC-PLC is an important component of macrophage activation by LPS.


Subject(s)
Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Lipopolysaccharides/pharmacology , Macrophages, Alveolar/enzymology , Mitogen-Activated Protein Kinases , Type C Phospholipases/physiology , Bridged-Ring Compounds/pharmacology , Ceramides/biosynthesis , Enzyme Activation , Humans , Mitogen-Activated Protein Kinase 1 , Mitogen-Activated Protein Kinase 3 , Norbornanes , Protein Kinase C/physiology , Sphingomyelin Phosphodiesterase/physiology , Thiocarbamates , Thiones/pharmacology
16.
J Biol Chem ; 273(25): 15714-8, 1998 Jun 19.
Article in English | MEDLINE | ID: mdl-9624168

ABSTRACT

The lung is the major site expressing plasma phospholipid transfer protein (PLTP) mRNA in humans and mice, suggesting that this protein might have an important role in maintaining normal function of this organ. In the lung of human collagenase transgenic mice, an emphysematous animal model, PLTP mRNA was 3-fold higher than in control mice. However, the mRNA in other tissues was not changed. To further assess the expression and function of PLTP, we measured PLTP mRNA level in lung tissue of two emphysematous patients and found that the mRNA was 4-fold higher than in control subjects. In situ hybridization on mouse lung suggested positive staining in alveolar type II epithelial cells. In addition, immortalized rat alveolar pre-type II epithelial cells and freshly isolated mature rat alveolar type II epithelial cells both highly expressed PLTP mRNA, and the former cells actively secreted PLTP activity into the medium. To examine the possible mechanisms leading to high levels of PLTP expression in vivo, we exposed the pre-type II cells to hypoxia and demonstrated induction of PLTP mRNA and a coordinate increase in secreted PLTP activity. Thus, the PLTP gene is highly expressed in alveolar type II epithelial cells and is induced during hypoxia and in emphysema. These observations suggest that a hypoxic stimulus occurring in emphysema may be a novel mechanism that contributes to enhanced expression of PLTP.


Subject(s)
Ca(2+) Mg(2+)-ATPase/metabolism , Carrier Proteins/biosynthesis , Emphysema/metabolism , Gene Expression Regulation , Hypoxia/metabolism , Lung/metabolism , Membrane Proteins/biosynthesis , Phospholipid Transfer Proteins , Phospholipids/metabolism , RNA, Messenger/metabolism , Animals , Blotting, Northern , Carrier Proteins/genetics , Collagenases/genetics , Collagenases/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Disease Models, Animal , Helix-Loop-Helix Motifs , Humans , Hypoxia-Inducible Factor 1 , Hypoxia-Inducible Factor 1, alpha Subunit , Membrane Proteins/genetics , Mice , Mice, Transgenic , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Rats , Transcription Factors/metabolism
17.
Am J Respir Cell Mol Biol ; 16(5): 605-12, 1997 May.
Article in English | MEDLINE | ID: mdl-9160843

ABSTRACT

We investigated several indices involved in sphingomyelin metabolism in developing rat lung. The levels of sphingomyelin gradually increased during lung maturation, with highest levels observed postnatally. The content of sphingosine and ceramide, biologically active sphingomyelin degradation products, did not significantly change in microsomes during the prenatal period, but increased to peak levels in neonatal and adult lung, respectively. Sphingosine content increased 6-fold between the fetal (Day 21) and neonatal period. The developmental profiles of two enzymes involved in sphingomyelin synthesis, serine palmitoyltransferase and sphingomyelin synthase, were similar. Serine palmitoyltransferase activity increased progressively from the fetal to neonatal period, and plateaued at high levels in the adult lung. The activity of serine palmitoyltransferase correlated with the levels of endogenous sphingolipid in lung tissue. Sphingomyelin synthase activity also increased during fetal lung development, but attained highest levels at Day 21 gestation; postnatally, enzyme activity was detected at lower levels. The activities of the sphingolipid hydrolases, acid and neutral sphingomyelinase and acid and alkaline ceramidase, were elevated in fetal lung, thereafter declining to low levels after birth. Studies conducted in alveolar macrophages, fibroblasts, and alveolar type II epithelial cells revealed that these developmental changes in enzyme activities in lung tissue were also occuring globally at the cellular level and were not restricted to any specific cell population. These studies suggest that the developmental increase in lung sphingomyelin content is due to coordinate regulation of enzymes involved in the biosynthesis and degradation of sphingomyelin. These observations also suggest a regulatory role for serine palmitoyltransferase in the generation of long chain sphingoid bases.


Subject(s)
Lung/growth & development , Lung/metabolism , Sphingomyelins/metabolism , Acyltransferases/metabolism , Amidohydrolases/metabolism , Animals , Animals, Newborn , Ceramidases , Ceramides/metabolism , Embryonic and Fetal Development , Galactosylgalactosylglucosylceramidase/metabolism , Lung/embryology , Lung/enzymology , Microsomes/metabolism , Rats , Rats, Sprague-Dawley , Serine C-Palmitoyltransferase , Sphingomyelin Phosphodiesterase/metabolism , Sphingomyelins/biosynthesis , Sphingosine/metabolism , Transferases (Other Substituted Phosphate Groups)/metabolism
18.
J Clin Invest ; 99(8): 2020-9, 1997 Apr 15.
Article in English | MEDLINE | ID: mdl-9109447

ABSTRACT

Surfactant synthesis is critically dependent on the availability of fatty acids. One fatty acid source may be circulating triglycerides that are transported in VLDL, and hydrolyzed to free fatty acids by lipoprotein lipase (LPL). To evaluate this hypothesis, we incubated immortalized or primary rat alveolar pre-type II epithelial cells with VLDL. The cells were observed to surface bind, internalize, and degrade VLDL, a process that was induced by exogenous LPL. LPL induction of lipoprotein uptake significantly increased the rates of choline incorporation into phosphatidylcholine (PC) and disaturated PC, and these effects were associated with a three-fold increase in the activity of the rate-regulatory enzyme for PC synthesis, cytidylyltransferase. Compared with native LPL, a fusion protein of glutathione S-transferase with the catalytically inactive carboxy-terminal domain of LPL did not activate CT despite inducing VLDL uptake. A variant of the fusion protein of glutathione S-transferase with the catalytically inactive carboxy-terminal domain of LPL that partially blocked LPL-induced catabolism of VLDL via LDL receptors also partially blocked the induction of surfactant synthesis by VLDL. Taken together, these observations suggest that both the lipolytic actions of LPL and LPL-induced VLDL catabolism via lipoprotein receptors might play an integral role in providing the fatty acid substrates used in surfactant phospholipid synthesis.


Subject(s)
Lipoproteins, VLDL/pharmacology , Pulmonary Surfactants/biosynthesis , Animals , Cells, Cultured , Choline-Phosphate Cytidylyltransferase , Fatty Acids/biosynthesis , Humans , In Vitro Techniques , Lipoprotein Lipase/metabolism , Lipoproteins, VLDL/metabolism , Low Density Lipoprotein Receptor-Related Protein-1 , Nucleotidyltransferases/metabolism , Phosphatidylcholines/biosynthesis , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/metabolism , Rats , Receptors, Immunologic/metabolism , Receptors, LDL/metabolism
19.
Biochem J ; 318 ( Pt 1): 333-41, 1996 Aug 15.
Article in English | MEDLINE | ID: mdl-8761490

ABSTRACT

Glucocorticoids appear to play an integral role in stimulating surfactant synthesis by activating the rate-regulatory enzyme for phosphatidylcholine synthesis, CTP:cholinephosphate cytidylyltransferase (CT). The activity of liver CT, in vitro, has been shown to be inhibited by the sphingomyelin hydrolysis product, sphingosine. In order to investigate the mechanisms by which glucocorticoids alter CT activity, in vivo, we administered betamethasone (1 mg/kg intraperitoneally) sequentially to adult male rats for 5 days. Betamethasone increased CT activity 2-fold relative to control in whole lung. The hormone also increased membrane-bound activity, but did not affect cytosolic enzyme activity. Betamethasone modestly increased CT mRNA as determined by the reverse-transcription PCR and Southern analysis of PCR products, but did not alter the levels of immunoreactive enzyme in lung membranes as demonstrated by Western blotting. The hormone did, however, produce a nearly 3-fold increase in membrane-associated sphingomyelin, and co-ordinately a substantial decrease in the levels of sphingosine in lung membranes. Sphingosine, but not sphinganine, was a competitive, reversible inhibitor of lung CT with respect to the enzyme activator, phosphatidylglycerol. Betamethasone decreased the activities of the sphingomyelin hydrolases: acid sphingomyelinase by 33% and of alkaline ceramidase by 21%. The hormone also inhibited the generation of sphingosine from lysosphingomyelin in lung membranes. There was no significant effect of the hormone on serine palmitoyltransferase activity, the first committed enzyme for sphingolipid biosynthesis. Further, administration of L-cycloserine, an inhibitor of sphingosine formation, was shown to stimulate CT activity by 74% and increase disaturated phosphatidylcholine in alveolar lavage by 52% relative to control. These observations suggest that glucocorticoids up-regulate surfactant synthesis at the level of a key regulatory enzyme by significantly altering the availability of inhibitory metabolites resulting from sphingomyelin hydrolysis.


Subject(s)
Betamethasone/pharmacology , Glucocorticoids/pharmacology , Lung/enzymology , Nucleotidyltransferases/metabolism , Sphingomyelins/metabolism , Amidohydrolases/drug effects , Amidohydrolases/metabolism , Animals , Base Sequence , Blotting, Southern , Ceramidases , Choline-Phosphate Cytidylyltransferase , Cycloserine/pharmacology , Kinetics , Male , Molecular Sequence Data , Nucleotidyltransferases/antagonists & inhibitors , Nucleotidyltransferases/genetics , Phospholipids/metabolism , Phosphorylcholine/analogs & derivatives , Phosphorylcholine/metabolism , RNA, Messenger/analysis , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Sphingomyelin Phosphodiesterase/metabolism , Sphingomyelins/antagonists & inhibitors , Sphingosine/analogs & derivatives , Sphingosine/metabolism , Sphingosine/pharmacology , Up-Regulation
20.
J Cell Sci ; 108 ( Pt 6): 2361-8, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7673355

ABSTRACT

Glycoprotein 330 (gp330) is a member of a family of receptors related to the low density lipoprotein receptor (LDLR). Although several ligands have been shown to bind gp330 in solid-phase assays, the ability of gp330 to mediate ligand endocytosis has not been demonstrated. To develop a cellular model for gp330 function we screened a variety of cultured cell lines and identified several that expressed this protein, including immortalized rat type II pneumocytes and a human and two rodent tumor cell lines. Using type II pneumocytes, endocytosis of a previously described gp330 ligand, urokinase (uPA) complexed with plasminogen activator inhibitor-1 (uPA:PAI-1) and two new ligands, PAI-1 and pro-uPA, was demonstrated. RAP, the 39 kDa receptor-associated protein known to antagonize ligand binding to gp330 in solid-phase binding assays, completely inhibited both internalization and degradation of the radiolabeled ligands by type II pneumocytes. This suggested that the clearance of these ligands was dependent on either gp330 or the LDLR-related protein (LRP), which shares several ligand-binding characteristics with gp330. By using polyclonal antibodies to gp330, the cellular internalization and degradation of the ligands were inhibited by 30-50%; remaining ligand internalization and degradation activity could be partially inhibited by polyclonal antibodies against LRP. These findings indicate that gp330, like other LDLR family members, mediates endocytosis of its ligands. In addition, gp330 acts in concert with LRP in type II pneumocytes to mediate clearance of a variety of proteins involved in plasminogen activation, including uPA:PAI-1 complexes PAI-1 and pro-uPA.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Lung Neoplasms/metabolism , Lung/metabolism , Membrane Glycoproteins/metabolism , Plasminogen Activator Inhibitor 1/metabolism , Receptors, LDL/metabolism , Urokinase-Type Plasminogen Activator/metabolism , Animals , Antibodies, Monoclonal , Cells, Cultured , Endocytosis , Epithelial Cells , Epithelium/metabolism , Heymann Nephritis Antigenic Complex , Humans , Lung/cytology , Lung Neoplasms/pathology , Radioligand Assay , Rats , Recombinant Proteins/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...